World Health Summit: Addressing Sepsis on the Global and National Level – Oct 17, 14h CEST

Update Tuesday, October 18, 2022: The recording of the workshop is now available, embedded below.

Original article:

On Monday, October 17 at 14h CEST, the workshop ‘Addressing Sepsis on the Global and National Level’ will take place at the World Health Summit in Berlin, and you can join online (Zoom link) free of charge.

The workshop will be chaired by our very own Konrad Reinhart, Founding President of the GSA, and feature the following speakers:

  • Dr. Janet Diaz – World Health Organization (WHO) | World Health Emergency Programme | Clinical Management | Team Lead

  • Prof. Dr. Marcus Friedrich – Charité – Universitätsmedizin Berlin | Berlin Institute of Health (BIH) | Visiting Professor | Germany

  • Prof. Dr. Mohsen Naghavi – University of Washington | Institute for Health Metrics and Evaluation | Department of Global Health | Director of Subnational Burden of Disease Estimation | United States of America

  • Dr. Emmanuel Nsutebu – African Sepsis Alliance | Chair | United Arab Emirates

  • Prof. Dr. Niels C. Riedemann – InflaRx GmbH | CEO and Founder | Germany

About the Workshop

Sepsis is a global health emergency affecting approximately 50 million people each year and resulting in at least 11 million deaths worldwide. These figures represent 20% of all-cause global mortality and do not consider the added burden contributed by COVID-19 over the past two and a half years.
According to the World Health Organization, most sepsis deaths can be prevented through improved infection prevention, early recognition, and management of sepsis as an emergency, in the same way, a heart attack would be treated. Preventing global sepsis deaths, however, requires reinforcement of competencies on prevention, recognition, and management for all healthcare workers and increasing sepsis awareness at all levels of society, including among lay people, policymakers, and healthcare authorities.
Encouraging milestones in the global fight against sepsis have been the adoption of a sepsis resolution “Improving Prevention, Recognition, Diagnosis and Clinical Management of Sepsis” at the 2017 World Health Assembly and its inclusion in the agenda of the G7 Health Ministers’ Meeting in 2022.
We will address the global burden of sepsis and Antimicrobial Resistance (AMR), highlight initiatives in addressing sepsis in sub-Saharan Africa, and present data on the effectiveness of increasing awareness for sepsis and prioritizing sepsis on all levels. Discuss the impact of the implementation of quality improvement measures, such as the education of healthcare workers in the early recognition of deteriorating patients and the availability of rapid response teams on survival.
Finally, this workshop will provide insights into the poorly recognized potential of novel therapeutic approaches.

Marvin Zick